These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8652246)

  • 1. p53 immunoreactive stain and early colorectal adenocarcinomas.
    Hirota S; Kudo S; Hosobe S; Kobayashi T; Himori M; Ikeda M; Takemoto Y; Nomoto M; Aoyagi Y; Asakura H
    Eur J Cancer; 1995 Dec; 31A(13-14):2220-2. PubMed ID: 8652246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-67 and p53 immunoreactive stain and early colorectal neoplasms.
    Hirota S; Hosobe S; Ikeda M; Kobayashi T; Himori M; Takemoto Y; Asakura H
    J Exp Ther Oncol; 1996 Sep; 1(5):317-21. PubMed ID: 9414420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [P53 protein in adenocarcinoma of the large intestine].
    Paluszkiewicz P; Pawłowska-Wakowicz B; Cybulski M; Berbeć H
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
    Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
    Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
    Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
    Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein.
    Yasui W; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
    Virchows Arch; 1996 Sep; 429(1):13-9. PubMed ID: 8865848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p185 and p53 in benign and malignant colorectal lesions.
    Porcelli B; Frosi B; Terzuoli L; Arezzini L; Marinello E; Vernillo R; De Martino A; Vatti R; Minacci C
    Histochem J; 2001 Jan; 33(1):51-7. PubMed ID: 11352401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
    Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
    Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
    Hornick JL; Farraye FA; Odze RD
    Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
    Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
    Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma.
    Suzuki H; Matsumoto K; Koide A; Tada T; Fujino I; Okuda A; Shigemori C
    Surg Today; 1994; 24(1):85-7. PubMed ID: 8054784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.
    Rambau PF; Odida M; Wabinga H
    Afr Health Sci; 2008 Dec; 8(4):234-8. PubMed ID: 20589130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship among p53, stage, and prognosis of large bowel cancer.
    Nathanson SD; Linden MD; Tender P; Zarbo RJ; Jacobsen G; Nelson LT
    Dis Colon Rectum; 1994 Jun; 37(6):527-34. PubMed ID: 8200229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
    Zhang Hong
    Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
    Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
    Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2,p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
    Int J Cancer; 1996 Feb; 69(1):5-8. PubMed ID: 8600060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms.
    Yasugi A; Yashima K; Hara A; Koda M; Kawaguchi K; Harada K; Andachi H; Murawaki Y
    Oncol Rep; 2008 Jan; 19(1):41-7. PubMed ID: 18097574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
    Manne U; Myers RB; Srivastava S; Grizzle WE
    J Natl Cancer Inst; 1997 Apr; 89(8):585-6. PubMed ID: 9106651
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of p53 protein in colorectal adenomas and adenocarcinomas. Reliable application of the heat-induced antigen retrieval method to formalin-fixed, paraffin-embedded material.
    Hamana T; Kawai K; Serizawa A; Tsutsumi Y; Watanabe K
    Pathol Int; 1994; 44(10-11):765-70. PubMed ID: 7834078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.